Neumora Therapeutics

Watertown, MA · Founded 2019 · CIK 0001885522 · Medtech

neumoratx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$474M
1 Form D · Jan 2023
45 months since last filing
Contracts
—
No federal contracts on record
Patents
40
15 granted · 25 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$474,356,988
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1909CONCENTRIS SYSTEMS LLC——
1910CLAIRWAYS LLC——
1911Nine Continents Medical Inc——
1912Neumora Therapeutics—$474M
1913Sanguine Diagnostics And Therapeutics, Inc.——
1914GUANINE, INC.——
1915Advanced Biosensors Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 10 related persons
  • Paul BernsDirector · Executive Officer
  • Kristina BurowDirector
  • Matthew FustDirector
  • Alaa HalawaDirector
  • Maykin HoDirector
  • Robert NelsenDirector
  • Joshua PintoExecutive Officer
  • Kari StefanssonDirector
  • Tamara TompkinsExecutive Officer
  • Stacie WeningerDirector

Patents

USPTO · 15 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.